Experimental basis of innovative therapies of rheumatoid arthritis.
Shiroky
J B
JB
Division of Rheumatology, Montreal General Hospital, Que., Canada.
Yocum
D E
DE
Wilder
R L
RL
Klippel
J H
JH
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D002908:Chronic Disease; D003524:Cyclosporins / Q000627:therapeutic use; D005227:Fatty Acids / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D012460:Sulfasalazine / Q000627:therapeutic use; D013951:Thymus Hormones / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D005227:Fatty Acids; D013951:Thymus Hormones; D012460:Sulfasalazine; D007372:Interferons; D008727:Methotrexate